#None #Wilmington #Chemours #Opteon #Freon

Introduction

The Chemours Company has released its financial results for the first quarter of 2026, revealing a complex picture of growth and challenges. Despite a slight increase in overall net sales, the company also recorded a significant net loss, reflecting the ongoing hurdles faced by the global chemistry giant.

Key Financial Highlights

For the first quarter ending March 31, 2026, Chemours reported net sales of $1.4 billion, a modest increase of 1% from the previous year. This growth can be largely attributed to their Thermal and Specialized Solutions (TSS) division, which achieved record sales, partially driven by the increasing popularity of Opteon™ Refrigerants. However, the company experienced a net loss of $29 million, which is a stark contrast compared to a net loss of just $5 million in the same quarter last year. This translates to a loss of $0.19 per diluted share versus the previous year’s $0.03.

Interestingly, adjusted net income stood at $8 million or $0.05 per diluted share, down from $19 million or $0.13 per diluted share in Q1 2025. Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) showed a slight increase to $169 million, which is a modest improvement from $166 million year-over-year.

Segment Performance Analysis

Chemours' performance varied across different segments, with TSS showing promising results:

• - Thermal and Specialized Solutions: This segment reported $568 million in net sales, reflecting a robust 22% increase compared to the previous year. Notably, sales of Opteon™ Refrigerants grew by 12%, alongside a remarkable 67% increase in Freon™ Refrigerants sales.
• - Titanium Technologies: Facing challenges, this division recorded net sales of $559 million, down 6% year-over-year. This decline can be attributed to a 7% drop in sales volumes, significantly affected by reduced TiO2 sales in North America.
• - Advanced Performance Materials (APM): The APM segment witnessed a substantial 17% drop in net sales, totaling $243 million. This downturn was exacerbated by ongoing operational constraints in production facilities and unfavorable market conditions.

Financial Strategy and Future Advisories

Despite the challenges reflected in the net loss and the fluctuations in sales across divisions, Chemours is showcasing a commitment to its Pathway to Thrive strategy, aiming for long-term sustainability and growth. Denise Dignam, President and CEO of Chemours, emphasized the importance of effective execution and adaptability in the face of continuous economic uncertainty. The company aims to leverage opportunities in the marketplace, capitalizing on strengths in the TSS sector while navigating through potential hurdles in other areas.

Additionally, Chemours successfully completed the sale of its Kuan Yin site, resulting in approximately $287 million in cash proceeds, intended for de-leveraging debt, which currently stands at $4.2 billion. These financial moves indicate a strategic approach towards improving liquidity and reducing financial burdens.

Looking Ahead

As Chemours moves into the second quarter of 2026, expectations are optimistic, with forecasts of a potential 15% to 20% increase in consolidated net sales driven by seasonal trends. The operational performance across its segments, especially in TSS, is anticipated to push for improvements in Adjusted EBITDA, which is expected to range between $220 million and $250 million.

Conclusion

In summary, while the Chemours Company's first-quarter results for 2026 reflect certain pressures and setbacks, the strides made in particular segments such as TSS showcase the potential for recovery and growth. The company is strategically addressing its debt through asset sales while continuing to adapt its operations to the evolving market dynamics. With a keen eye on upcoming opportunities, Chemours seems poised to navigate the uncertainties ahead and work towards a more stable financial standing.